About Jeffrey Barnes, MD, PhD

Jeffrey Barnes, MD, PhD is a graduate of the University of Illnois College of Medicine. He completed his residency in Internal Medicine at the Beth Israel Deaconess Medical Center in Boston. He then completed his fellowship in Medical Oncology at the Dana Farber Cancer Institute before joining the faculty at the Massachusetts General Hospital. He is a member of the US Cutaneous Lymphoma Consortium. His research interests focus on the identification and evaluation of novel agents for the treatment of lymphoma.

Clinical Interests:

Treats:

Locations

Mass General Cancer Center: Hematology Oncology
55 Fruit St.
Boston, MA 02114
Phone: 617-724-4000
Fax: 617-726-8330

Martha's Vineyard Hospital
1 Hospital Rd.
Oak Bluffs, MA 02557
Phone: 508-693-0410

Mass General Cancer Center at Newton-Wellesley
2014 Washington St.
Newton, MA 02462
Phone: 617-219-1230

Medical Education

  • , University of Illinois College of Medicine at Urbana-Champaign
  • Fellowship, Dana Farber Cancer Institute

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.


Research

Dr. Barnes performs translational research in lymphoma including clinical trials of novel therapies for the treatment of cutaneous lymphoma, non-Hodgkin lymphomas, Hodgkin lymphoma (Hodgkin's disease), and chronic lymphocytic leukemia.

Publications

  • Select Publications:

    • Barnes JA, Abramson JS. Differential Diagnosis and Novel Treatment Strategies for Adult T Cell Leukemia Lymphoma. Oncology. Dec 23;14, p.1267-1270 (2009)
    • Abramson JS, Hellmann M, Barnes JA, Hammermann P, Toomey C, Takvorian T, Muzikansky A, Hochberg EP. Intravenous methotrexate as central nervous system prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma. Cancer Jun 8 Epub ahead of print (2010)
    • Barnes JA, LaCasce AS, Zukotynski K, Israel D, Feng Y, Neuburg D, Tomey C, Hochberg EP, Canellos GP, Abramson JS. End of treatment but not interim PET scan predicts outcomes in non-bulky limited stage Hodgkin lymphoma. Ann of Oncology  Oct 15 (2010)
    • Barnes JA, LaCasce AS, Feng Y, Tomey C, Neuburg D, Michaelson JS, Hochberg EP, Abramson JS. Evaluation of the Addition of Rituximab to CODOX-M/IVAC for Burkitt Lymphoma: A Retrospective Analysis. Ann of Oncology In Feb 21 (2011)

Reviews: Comments and Ratings

4.9out of 5(377 Ratings, 152 Comments)

April 2025

I'm still amazed at how efficient and thorough Dr. Barnes, his staff and the lab are. Always a great experience.


March 2025

Dr Barnes took the time to explain the results of tests and action plan moving forward.


March 2025

Dr. Barnes is extremely professional and informative re every aspect of my healthcare. He has a lovely, supportive demeanor and strives to enlighten my family and myself re every aspect of my care and prognosis. This raises our comfort level, reduces anxiety and ultimately enhances healing and quality of life....which we truly appreciate!


March 2025

My experience with this care provider has always been good. I have no complaints at all.


March 2025

Dr. Barnes is a no nonsense professional. Made me feel at ease during my visit.


March 2025

one word says it all: EXCELLENT.


March 2025

I've been seeing Dr Barnes for around10 years and I wouldn't be here if not for Dr Barnes and the teams at MGH.


March 2025

Dr Jeffrey Barnes is a very intelligent Dr. He takes the time to listen and answer all my questions in a very intelligent and friendly way. I trust Dr Barnes and recommend him to anyone with the same condition as myself.


March 2025

The care provider is excellent, the construction is horrid and very confusing with the sidewalks shut off


March 2025

This was the first time that I met Dr. Barnes. He has a great personality and a great sense of humor to go along with his personality. He was good with explaining the reason I was seeing him, explained the results of my tests, and let me know that I didn't need to see him for a year. A very enjoyable visit. But - I was also relieved that the ... Read More

View More
Ratings and Comments Powered by NRC Health